 Eidos Therapeutics Inc NASDAQ:EIDX Research analysts at Svb Leerink lifted their Q1 2020 EPS estimates for Eidos Therapeutics in a research report issued to clients and investors on Thursday, February 27th. Svb Leerink analyst M. Foroohar now forecasts that the company will post earnings per share of 0.58 for the quarter, up from their ... 